Embed Size (px)
Citation preview
Project Completion ReportPlease submit through your APEC Secretariat Program Director within 2 months of
project completion.
SECTION A: Project profileProject number &
title:HWG 03/111A - APEC Workshop on Influenza Vaccine Policies and Strategies in Post-Pandemic Era
Time period coveredin report: 1/07/2011-31/07/2012
Date submitte
d:30/8/2012
Committee / WG / Fora: Health Working Group
Project Overseer Name /
Organization / Economy:
Prof. Feng-Yee ChangCenters for Disease ControlChinese Taipei
SECTION B: Project report and reflectionBriefly answer each of the questions below. Section B should be a maximum of 2-3 pages, inclusive of the questions and tables provided.
1. Project description: In 3-4 sentences, describe the project and its main objectives.This project is designed to help member economies to formulate more effective influenza vaccination policies and strategies in the post pandemic periods and help enhance information and experience sharing in terms of influenza vaccine policies and strategies through lecture, group discussion and group report. The workshop was divided into different sessions, including “Vaccination Policy Formulation”, “Vaccination Program Implementation”, “Vaccine Safety Monitoring” and “Communication for Vaccination Programme”. Each session focused on a topic with the view to achieving the objectives set forth for the workshop.
2. Meeting your objectives: Were the proposed objectives of the project met? If so, please describe how. If not, please include any major changes to the proposed scope of the project. Please outline any problems you may have encountered that resulted in delays to the delivery of the activity. The workshop was held successfully in Taipei on 18-20 July 2012. The workshop gathered 25 delegates from 13 APEC member economies, including Australia, Chile, China, Hong Kong, Indonesia, Japan, Korea, Malaysia, Papua New Guinea, the Philippines, Thailand, the United States and Vietnam, and 74 experts from Chinese Taipei. Three key objectives of the project listed below were achieved at the end of the workshop. (1) To formulate more effective vaccination policies and strategies through exchange of
information and sharing of experience--- During the workshop, the speeches, presentations and every participant’s ardent discussion all contributed significantly to the formulation of better vaccination policies and strategies. The workshop provided a good opportunity and platform for all participants from the APEC region to exchange and share experience and information on vaccination policies and strategies through thorough discussion.
(2) To identify the major challenges and constraints in APEC economies’ vaccination programsand to enhance APEC member economies’ capacity of pandemic preparedness in the post-pandemic periods--- The moderators and speakers from WHO Collaborating Centers for Reference and Research on Influenza, CDC and FDA were invited to share successful examples and best practices in implementing vaccination programs. And also through the group discussion and group report, participants were encouraged to share and discuss their vaccination program with others. It helped participants to identify the major challenges and constrains in their vaccination programs and enhanced their capacity of pandemic preparedness in the post-pandemic era.
(3) To create an expert network on formulation and implementation of vaccination policies and Strategies--- The moderators, speakers, experts and participants’ contact information were collected and distributed to all participants. Participants can utilize this expert network for sustained sharing of information and collaboration on researches with others after the workshop.
3. Evaluation: Describe how you evaluated the project upon completion? Detail the results of the evaluations conducted, if any (e.g. participant evaluation, peer review of publication, measurement of indicators, statistics demonstrating use of outputs etc.).
During the group discussion for each session, well-trained instructors were assigned to each group to lead an effective discussion. The discussion topics and questions were prepared and included in the group handbook. In order to evaluate participants’ learning and discussion result, each group was requested to submit a group report and share the group’s findings and suggestions.
At the end of the workshop, an evaluation survey was conducted to evaluate speaker/participant satisfaction with the workshop. Not only did most of them consider this workshop has achieved its objectives through sharing of experience and information on vaccination policies and strategies, they also gave numerous positive feedbacks concerning the excellent workshop arrangement and the warm hospitality extended to them by the workshop organizer.
4. Key findings: Describe the main outputs delivered and any broader outcomes achieved as
a result of this project. (For example have there been any capacity building outcomes, policy or operational changes, or changes to standards or systems as a result of this activity?) Describe how project outputs relate to fora/sub fora/working group strategic and medium-term priorities and strategic priorities. Please provide examples of important findings or lessons learned arising from the project.
This workshop has proven APEC an excellent platform to gather experts from APEC member economies to exchange information and share experiences. The sharing of experience and best practice with the invited speakers and group members facilitated the developing economies in identifying major challenges and constrains in their economies, thus enhancing their capacity of pandemic preparedness in the post pandemic period. The participants expressed that the information they gained from the workshop was very useful. They can use the information learned to compare the influenza vaccine policies implemented in different economies and figure out the suitable vaccination policies and strategies for their own economies. In addition, they expressed that they will apply what they learned during the workshop to further improve and revise their national pandemic influenza preparedness plans.
Moreover, the expert network established through the workshop allows the developing economies to consult and exchange information with other experts that are from developed economies and other international organizations. The participants expressed that the workshop presented a great opportunity to meet appropriate experts who are knowledgeable in the field of vaccination policies and strategies. The networking opportunity with other APEC economies was very fruitful. The participants can keep close contact with one another through the expert network to exchange suggestion and recommendation after the workshop.
This project is a direct response to the APEC HWG medium term workplan (2010 – 2015) as it aims to enhance preparedness for and effective management of emerging and re-emerging infectious diseases, vector-borne diseases, HIV/AIDS and pandemics. The knowledge and information gained from the workshop enable the participants to make a better preparedness vaccination plan for future pandemic.
5. Next steps: Describe any follow-up steps or projects that are planned following the completion of the activity, such as post-activity evaluations or tracer studies planned to assess the impact of this activity. Have the results of the activity been disseminated to participants and other stakeholders and how? What are (if any) any flow-on effects from this activity? How will this activity inform any future APEC activities? The workshop documents, training materials and expert list were uploaded to the Health Working Group website after the workshop. Chinese Taipei will pay close attention to the feedback received from participants and provide them with the necessary assistance on formulation and implementation of vaccination policies and strategies accordingly.
Moreover, the news of workshop activities and result was released to the public through Chinese Taipei CDC’s official web site after the workshop. And also the speakers’ speeches will be uploaded to the Chinese Taipei CDC e-learning website for participants’ further learning.
6. Feedback for the Secretariat: Do you have any suggestions for more effective
management of projects in the future? Any assessment of consultants, experts or participants that you would like to share? (The Secretariat collates and examines feedback to identify trends for ongoing evaluation of our project management and/or communications systems.)
Suggestion: We would like to make a suggestion concerning participants from travel-eligible APEC member economy applying for APEC funding. As the APEC funded participants’ details and tasks are completed by organizer and submitted to the APEC Secretariat for funding approval, to trace the process of APEC funding approval effectively, we would like to suggest the APEC Secretariat could process the compiling of data, including the applicants’ information, the date of receiving the itinerary and airfare quotation and the advanced payment approval date etc., and present the information in a consistent format instead of merely forwarding the email containing the applicant’s response one by one and the funding progress schedule to the organizer, making the management of projects more effective.
7. Participant information: Please provide details, where applicable. Insert rows as needed.Economy # male # female Details
Australia 1 1 Ian Gust, Julianne QuaineBrunei Darussalam 0 1 Sok King OngChina 1 1 Meiqi Hu, Haijun SuHong Kong, China 1 0 Thomas Ho Fai TsangIndonesia 1 1 Arie Bratasena, Sulistya WidadaJapan 1 1 Junko Nakatsuka, Masato TashiroRepublic of Korea 1 1 Young-Joon Park, Soon-Ryu SeoMalaysia 0 2 Rohani Jahis, Husna Maizura Ahmad MahirPapua New Guinea 1 1 Rosheila Dagina, James Materua AminiThe Philippines 0 3 Cecilia Ladines-Llave, Ma. Luisa Paran, Marlyn ConvocarThailand 1 1 Charung Muangchana, Suchada JiamsiriThe United States 2 0 Jonathan Schwartz, Steven BlackViet Nam 2 0 Hoa Le Kim, Pham Van Hung
Chinese Taipei 35 39
Chang Chao-Ching, Chang Chia-Chi, Chang Feng-Yee, Chang Luan-Yin, Chao Yen-Nan, Chen Don-Yun, Chen Pei-Yu, Chen Po-Yen, Chen Wan-Chin, Cheng An-Hua, Chi Chin-Sheng, Chiang Yu-Chyn, Chien Hui-Yi, Chih Yi-Chien, Chiu Wen-Ta, Chou Chien-Yu, Chou Jih-Haw, Chou Yu-Ming, Chu Yu-Roo, Fu Ying-Hsien, Ho Chi-Kung, Ho Li-Li, Hsiung Chao, Hsiung Hsien-Ya, Hsu Chien-Ting, Hsu Mei-Ling, Hsu Yu-Fen, Huang Fu-Yuan, Huang Hsiau-Wen, Huang Shao-Chin, Huang Song-En Angela, Huang Y. W. Ruby, Hung Min-Nan, Kao Chuan-Liang, Ke Yu-Fen, Kuo Hung-Wei, Lee Chia-Chi, Lee Chia-Lin, Lee Min-Shi, Lin Hui-Chen, Lin Ju-Ru, Lin Kuo-Ning, Lin Tzou-Yien, Liu Ching-Chuan, Liu Ming-Ching, Liu Ming-Tsan, Liu Wu-Tse, Liu Yi-Lien, Liu Yu-Lun, Lo Yi-Chun, On W.F. Angela, Shieh Chun-Fu, Su Chia-Ping, Su Ih-Jen, Tang Ren-Bin, Tsai Hsiao-Yun, Tsai Kun-Ju, Tsai Wei-Hsuan, Tsai Yi-Jen, Tsai Yin-Hua, Tseng Shiu-Ling, Tu Chih-Tsung, Tzou Meir-Chyun, Wang Joyce, Wang Ping-Cheng, Wang Wei-Fang, Wei Sung-His, Wu Ho-Sheng, Wu Hsiu, Yang Chin-Hui, Yang Ji-Rong, Yang Shih-Yan, Yang Shu-Er, Yeh Horng-I
7. Outputs: Please provide details, where applicable. Change headings or insert rows as needed. # planned # actual Details
# of workshops / events 1 1 APEC Workshop on Influenza Vaccine Policies
and Strategies in Post-Pandemic Era
# of publications distributed 50-60 200 100 workshop program books and 100 group handbooks were distributed respectively.
# of CDs distributed 0 0
# of websites created 0 0
Other: 0 100 The workshop information and training materials were stored in the USB disks and distributed.
SECTION C: BudgetAttach a detailed breakdown of the APEC- provided project budget, including:
Planned costs (using most recently approved budget figures) Actual expenditures Variance notes: An explanation of any budget line under- or over-spent by 20% or more.
Items No. of Units Unit Rate APEC Funding (USD)
Self Financing (USD)
Actual Expenditure
Direct Labour 2160 18,060 16,620
Speaker’s Honorarium
6 speakers 360 2,160
4 speakers 360 1,440 0
Consultant 3 consultant×2 times＝6 times
70/time
(3 hours)
420 420
Secretariat Support
3 assistants×4 months＝12
1200/month (200hours)
14,400 14,400
Computer Engineer
1 person
×3days＝1 day1
100/day
(8 hours)
300 300
Temporary Assistant
5persons×3days＝15
100/day (8 hours)
1500 1500
Travel 64,723 47,760 29,440
- Per Diem (Speakers/Experts)
Taipei-4days
10persons
294/day/
person
11,760 11,440
-Airfare (Speakers/Experts)
10 trips to Taipei(business class)
4,000×6 2,000×6
36,000 18,000
- Per Diem (only from travel-eligible economies)
Taipei-4days
22 persons
294/person/day 4.75days (4days + 75% one-off additional payment)
30,723
Funding approved and paid by APEC
Secretariat-Airfare (only from travel-eligible economies)
22 trips to Taipei(econom
2,200×10 1,000×12
34,000
Items No. of Units Unit Rate APEC Funding (USD)
Self Financing (USD)
Actual Expenditure
ic class)
Publication of report (including distribution)
300 copies 3,000 3,000
Equipment / Materials (describe briefly what is required and why)
Printer, computer, photocopier, LCD projector, Office supplies etc.
8,000 8,000
Local transportation
1,500 1,500
Photocopying 1,000 1,000
Communications (Phone/ Fax/ Mail/ Courier)
3,000 3,000
Hosting Conference room rental, Meals and receptions
21,000 21,000
other
Total $ 66,883 $103,320 $83,560
(Self Financing)
SECTION D: Appendices or additionsPlease attach any of the following. This information will help us better understand your project, support overseers of similar projects and plan for future projects. List of experts or consultants utilized, with job titles and contact details, gender
disaggregated where possible. Please see attached file
List of participants, with job titles and contact details Please see attached file
Event agendas Please see attached file
Links to any relevant websites or online material (e.g. reports, resources created) APEC Health Working Group Website (http://www.apechwg.org/pub/News.asp) Chinese Taipei Centers for Disease Control website
(http://www.cdc.gov.tw/info.aspx?treeid=45da8e73a81d495d&nowtreeid=1bd193ed6dabaee6&tid=DF4FBCF148BC2B8D)
Results of participant feedback or other project evaluation (raw and/or analyzed)
Please see attached file
Any other relevant information or resources that would help us learn more about your
project Nil
FOR APEC SECRETARIAT USE ONLY APEC comments: Were APEC project guidelines
followed? Could the project have been managed more effectively or easily by the PO?
List of experts # Photo Name Position Organization Email Telphone
1 Ian Gust Professorial Fellow
Department of Microbiology and Immunology, The University of Melbourne, Australia
+61-3-83443963
2 Masato Tashiro Director
WHO Collaborating Centre for Reference and Research on Influenza;Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
[email protected] +81-42-565-2498
3 Cecilia Ladines-Llave Professor
Department of Gynecologic Oncology, University of the Philippines-Philippine General Hospital. Chair, The Cancer Institute Foundation, Philippine
+63-842-0032
4 Young-Joon Park Medical
Officer
Division of Vaccine Preventable Diseases Control and National Immunization Programme, Korea CDC
+82-43-719-7354
5 Steven Black Professor of Pediatrics
Center for Global Health, University of Cincinnati Children's Hospital, USA
+1 (510)-219-7372
6 Thomas Ho Fai Tsang Controller
Centre for Health Protection , Department of HealthHong Kong SAR
+852-2961-8889
7 Angela W. F. On
Chief Executive Director
National ADR Reporting System, Taiwan Drug Relief Foundation
+886-2-2358-7343
8 Mei-Ling Hsu Professor
Department of Journalism, College of CommunicationNational Chengchi University
+886-2-293-87429
9 Don-yun Chen Professor
Department of Public Administration, National Chengchi University
[email protected] +886-937816334
10 Feng-Yee Chang Director-
GeneralCenters for Disease Control, Chinese Taipei
+886-2-2395-9825 ext:3910
11 Meir-Chyun Tzou Division
Director
Division of Drugs and New Biotechnology Products Food and Drug Administration, Chinese Taipei
+886-2-27878099, +886-2-27878000
12 Fu-Yuan HuangProfessor /
Senior Attending Physician
Pediatric Department, Mackay Memorial Hospital, Chinese Taipei
+886--2543-3535 ext:2002
13 Jih-Haw ChouDeputy
Director-General
Centers for Disease Control, Chinese Taipei.
[email protected] +886-2-2394-5203
14 Tzou-Yien Lin Deputy
MinisterDepartment of Health, Chinese Taipei
+886-2-8590-6666
15 Ih-Jen SuDistinguishe
d Investigator and Director
National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Chinese Taipei
[email protected]@nhri.org.tw
+886-6-2083426
List of Participants
Australia Ian Gust Current Position: Professor Organization: Department of Microbiology and Immunology, The University of
MelbourneE-mail: [email protected] Tel: +61-3-83443963
Julianne Quaine Current Position: Assistant Secretary (Branch Head) Organization: Health Protection Programs Branch, Office of Health Protection,
Department of Health and Ageing E-mail: [email protected] Tel: +61-2-6289-7705
Brunei Darussalam Sok King Ong Current Position: Acting SpecialistOrganization: Environmental Health Services, Department of Health Services,
Ministry of HealthE-mail: [email protected] Tel: +673-898-2348
China Meiqi Hu Current Position: Division DirectorOrganization: Department of International Cooperation, Ministry of Health E-mail: [email protected] Tel: +86-10-68772282
Haijun Su Current Position: Division Director Organization: Bureau of Disease Control, Ministry of Health Tel: +86-10-68792335
Hong Kong, China Thomas Ho Fai Tsang Current Position: ControllerOrganization: Centre for Health Protection, Department of HealthE-mail: [email protected] Tel: +852-2961-8889
Indonesia Andi Muhadir Current Position: Director Organization: Directorate of Surveillance, Immunization, Quarantine and Matra
Health, Diseases Control and Environmental Health, Ministry of Health E-mail: [email protected]
Arie Bratasena Current Position: Head Organization: Sub-directorate of Acute Respiratory Track Infection, Directorate of
Communicable Disease, Ministry of Health E-mail: [email protected] Tel: +6221-42873461
Sulistya Widada Current Position: Head Organization: Section of Guidance and Evaluation of Immunization, Directorate of
Surveillance, Immunization, Quarantine and Matra Health, Diseases Control and Environmental Health, Ministry of Health
E-mail: [email protected] Tel: +6221-4249024
Japan Junko Nakatsuka Current Position: Deputy Director Organization: Office of Pandemic Influenza Preparedness & Response, Division of Tuberculosis and Infectious Diseases Control, Health Service Bureau, Ministry of
Health, Welfare and Labour E-mail: [email protected] Tel: +81-3-3595-3426
Masato Tashiro Current Position: DirectorOrganization: WHO Collaborating Centre for Reference and Research on Influenza;
Influenza Virus Research Center, National Institute of Infectious Diseases, TokyoE-mail: [email protected] Tel: +81-42-565-2498
Republic of Korea Young-Joon Park Current Position: Medical OfficerOrganization: Division of Vaccine Preventable Diseases Control and National
Immunization Programme, Korea Centers for Disease Control and Prevention E-mail: [email protected] Tel: +82-43-719-7354
Soon-Ryu Seo Current Position: Research Officer Organization: Chronic Disease Control Division, Korea Centers for Disease Control
and Prevention E-mail: [email protected] Tel: +82-43-719-7384
Malaysia Rohani Jahis Current Position: Senior Principal Assistant Director Organization: Disease Control Division, Department of Public Health, Ministry of
HealthE-mail: [email protected] Tel: +603-8883-4411
Husna Maizura Ahmad Mahir Current Position: Public Health Physician/Senior Principal Assistant Director Organization: Disease Control Division, Department of Public Health, Ministry of
Health E-mail: [email protected] Tel: +603-8883-4508
Papua New Guinea Rosheila Dagina Current Position: Technical Officer Organization: Disease Surveillance, National Department of Health E-mail: [email protected]; [email protected] Tel: +675-3236179
James Materua Amini Current Position: Chief Paediatrician Organization: National Department of Health E-mail: [email protected] Tel: +675-3248200; +675-76826548
The Philippines Cecilia Ladines-Llave Current Position: Professor Organization: Department of Gynecologic Oncology, The Cancer Institute Foundation, University of the Philippines Manila - Philippine General Hospital E-mail: [email protected] Tel: +63-842-0032
Ma. Luisa Paran Current Position: Medical Specialist II, Infectious Disease Cluster Head Organization: Department of Health, Center for Health Development - Cordillera E-mail: [email protected] Tel: +63-74-444-5255
Marlyn Convocar Current Position: Officer-In-Charge, Director IV Organization: Department of Health, Center for Health Development - Region 12 E-mail: [email protected] Tel: +63-64-421-2373
Chinese Taipei Chang Chao-Ching Current Position: Director Organization: Fifth Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-7-556-5803
Chang Chia-Chi Current Position: Officer Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3672
Chang Feng-Yee Current Position: Director-General Organization: Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3910
Chang Luan-Yin Current Position: Professor Organization: Department of Pediatrics, National Taiwan University Hospital E-mail: [email protected] Tel: +886-2-2312-3456 ext:71528
Chao Yen-Nan Current Position: Medical Officer Organization: Second Division, Centers for Disease Control E-mail: [email protected] Tel: +886-919-353-175
Chen Don-Yun Current Position: Professor Organization: Department of Public Administration, National Cheng-chi University E-mail: [email protected] Tel: +886-2-2939-3091 ext: 51145
Chen Pei-Yu Current Position: Assistant Technical Specialist Organization: Vaccine Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2785-0513 ext:606
Chen Po-Yen Current Position: Chairman Organization: Pediatric Infectious Disease, Taichung Veterans General Hospital E-mail: [email protected] Tel: +886-933-189415
Chen Wan-Chin Current Position: Medical Officer Organization: First Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext: 5027
Cheng An-Hua Current Position: Deputy Director Organization: First Division, Centers for Disease ControlE-mail: [email protected] Tel: +886-2-2395-9825 ext: 3011
Chi Chin-Sheng Current Position: Assistant Technical Specialist Organization: Fourth Branch, Centers for Disease Control E-mail: [email protected]: +886-6-2696211 ext: 102
Chiang Yu-Chyn Current Position: Section Chief Organization: Public Health Bureau of Taoyuan County E-mail: [email protected] Tel: +886-3-334-0935 ext: 2100
Chien Hui-Yi Current Position: Program CoordinatorOrganization: First Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext: 3007
Chih Yi-Chien Current Position: Section ChiefOrganization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext: 3665
Chiu Wen-Ta Current Position: Minister Organization: Department of Health Tel: +886-2-8590-6666
Chou Chien-Yu Current Position: Assistant Technical Specialist Organization: First Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-975-030773
Chou Jih-Haw Current Position: Deputy Director-General Organization: Centers for Disease Control E-mail: [email protected] Tel: +886-2-23945203
Chou Yu-Ming Current Position: Senior Specialist Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-23959825 ext: 3090
Chu Yu-Roo Current Position: Division ChiefOrganization: Department of Health, Taipei City Government E-mail: [email protected] Tel: +886-966-601615
Fu Ying-Hsien Current Position: Executive Officer Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration E-mail: [email protected] Tel: +886-2-2787-7441
Ho Chi-Kung Current Position: Director General Organization: Department of Health, Kaohsiung City Government E-mail: [email protected] Tel: +886-7-724-3327
Ho Li-Li Current Position: Section Chief Organization: Public Relations Office. Centers for Disease Control, E-mail: [email protected] Tel: +886-928-130490
Hsiung Chao Current Position: Director Organization: Institute of Population Health Science, National Health Research Institutes E-mail: [email protected] Tel: +886-37-246-166 ext:36100
Hsiung Hsien-Ya Current Position: Nurse Organization: Public Health Bureau of Miaoli County E-mail: [email protected] Tel: +886-3-7330002 +886-928-975776
Hsu Chien-Ting Current Position: Contract Staff Organization: Public Health Bureau of Miaoli County E-mail: [email protected] Tel: +886-037-336781
Hsu Mei-Ling Current Position: Professor Organization: Department of Journalism, College of Communication, National Chengchi University E-mail: [email protected] Tel: +886-2-25433535 ext:2002
Hsu Yu-Fen Current Position: Technical SpecialistOrganization: Epidemic Intelligence Center, Centers for Disease Control E-mail: [email protected] Tel: +886-3-3937720 ext:1025
Huang Fu-Yuan Current Position: Professor / Senior Attending Physician Organization: Pediatric Department, Mackay Memorial Hospital E-mail: [email protected] Tel: +886-2-25433535 ext:2002
Huang Hsiau-Wen Current Position: Senior Researcher Organization: Center for Science and Technology, Food and Drug Administration E-mail: [email protected] Tel: +886-2-2787-7037
Huang Shao-Chin Current Position: Assistant Researcher Organization: Vaccine Center, Centers for Disease Control E-mail: [email protected] Tel:+886-2-2785-0513ext:742
Huang Song-En Angela Current Position: Medical Officer Organization: Field Epidemiology Training Program Offices, Centers for Disease Control E-mail:[email protected] Tel: +886-919-404373
Huang Y. W. Ruby Current Position: Executive Officer Organization: Division of Drugs & New Biotechnology Products, Food and Drug
Administration E-mail: [email protected] Tel: +886-2-2787-7411
Hung Min-Nan Current Position: Medical Officer Organization: Fifth Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-933-620192
Kao Chuan-Liang Current Position: Associate Professor Organization: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University. E-mail: [email protected] Tel: +886-933-128081
Ke Yu-Fen Current Position: Section Chief Organization: First Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3057
Kuo Hung-Wei Current Position: Technical SpecialistOrganization: Epidemic Intelligence Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-3393-5073
Lee Chia-Chi Current Position: Section Chief Organization: Public Health Department, New Taipei City Government E-mail: [email protected] Tel:+886-2-2257-7155ext:1440
Lee Chia-Lin Current Position: Technical Specialist Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2391-9880
Lee Min-Shi Current Position: Associate Investigator Organization: National Health Research Institutes E-mail: [email protected] Tel: +886-037-246166 ext:35520
Lin Hui-Chen Current Position: Medical Officer Organization: Fifth Branch, Centers for Disease Control E-mail: [email protected]: +886-952-415076
Lin Ju-Ru Current Position: Section Chief Organization: Fourth Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-2395-9825 ext:3670
Lin Kuo-Ning Current Position: Assistant Director Organization: Department of Health, Taipei City Government E-mail: [email protected] Tel: +886-2-2375-9800 ext:1901
Lin Tzou-Yien Current Position: Deputy Minister Organization: Department of Health Tel: +886-2-8590-6666
Liu Ching-Chuan Current Position: Director Organization: Center for Infection Control, National Chengkung University E-mail: [email protected] Tel: +886-972-002882
Liu Ming-Ching Current Position: Assistant Technical Specialist Organization: Sixth Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-3-8242260
Liu Ming-Tsan Current Position: Associate ResearcherOrganization: Research and Diagnostic Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-26531108
Liu Wu-Tse Current Position: Professor Emeritus Organization: National Yang-Ming University E-mail: [email protected] Tel: +886-2-2783-4704
Liu Yi-Lien Current Position: Director General Organization: Public Health Bureau of Taoyuan County E-mail: [email protected] Tel: +886-3-332-4110
Liu Yu-Lun Current Position: Medical Officer Organization: Epidemic Intelligence Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-23959825 ext:3103
Lo Yi-Chun Current Position: Medical Officer Organization: Field Epidemiology Training Program Offices, Centers for Disease Control E-mail:[email protected] Tel: +886-989-066426
On W.F. Angela Current Position: Chief Executive Director Organization: Taiwan Drug Relief Foundation E-mail: [email protected] Tel: +886-2-2358-7343
Shieh Chun-Fu Current Position: Director General Organization: Public Health Bureau of Lienjang County E-mail: [email protected] Tel: +886-8-362-5231; +886-937-181506
Su Chia-Ping Current Position: Medical Officer Organization: Second Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-3-3983394
Su Ih-Jen Current Position: Director Organization: National Institute of Infectious Diseases and Vaccinology, National
Health Research Institutes E-mail: [email protected] Tel: +886-6-2083426, +886-6-2083422ext:65200
Tang Ren-Bin Current Position: Chairman Organization: Department of Pediatrics, Taipei Veterans General Hospital E-mail: [email protected] Tel: +886-966-285123
Tsai Hsiao-Yun Current Position: Associate Technical Specialist Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3889
Tsai Kun-Ju Current Position: Section Head Organization: Public Health Department, New Taipei City Government E-mail: [email protected] Tel: +886-2-2257-7155 ext:1444
Tsai Wei-Hsuan Current Position: Contract Staff Organization: Health Bureau of Keelung City E-mail: [email protected] Tel: +886-2-24230181 ext:147
Tsai Yi-Jen Current Position: Senior Reviewer Organization: Division of Drugs & New Biotechnology Products, Food and Drug Administration E-mail: [email protected] Tel: +886-2-2787-7428
Tsai Yin-Hua Current Position: Assistant Technical Specialist Organization: Vaccine Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2785-0513 ext:736
Tseng Shiu-Ling Current Position: Section Chief Organization: Health Bureau of Keelung City E-mail: [email protected] Tel: +886-2-2423-0181 ext:141
Tu Chih-Tsung Current Position: Section Chief Organization: Third Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-4-2473-9940 ext:218
Tzou Meir-Chyun Current Position: Director Organization: Division of Drugs and New Biotechnology Products, Food and Drug Administration E-mail: [email protected] Tel: +886-2-2787-7400
Wang Joyce Current Position: Senior Specialist Organization: Division of Drugs and New Biotechnology Products, Food and Drug Administration E-mail: [email protected] Tel: +886-2-2787-7403
Wang Ping-Cheng Current Position: Research Assistant Organization: First Division, Centers for Disease Control E-mail: [email protected] Tel: +886-916-935670
Wang Wei-Fang Current Position: Assistant Technician Organization: Public Health Bureau of Yilan County E-mail: [email protected] Tel: +886-3-932-2634 ext: 214
Wei Sung-Hsi Current Position: Medical Officer Organization: Third Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-4-2473-9940 ext:203
Wu Ho-Sheng Current Position: Director Organization: Research and Diagnostic Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2653-1377
Wu Hsiu Current Position: Medical Officer Organization: First Branch, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:4055
Yang Chin-Hui Current Position: Director Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-239509825 ext:3650
Yang Ji-Rong Current Position: Assistant Researcher Organization: Research and Diagnostic Center, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2785-0513
Yang Shih-Yan Current Position: Director Organization: First Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3010
Yang Shu-Er Current Position: Assistant Researcher Organization: Fourth Division, Centers for Disease Control E-mail: [email protected] Tel: +886-2-2395-9825 ext:3698
Yeh Horng-I Current Position: Technical Specialist Organization: Division of Drugs & New Biotechnology Products, Food and Drug Administration E-mail: [email protected] Tel: +886-2787-7452
Thailand Charung Muangchana Current Position: Director Organization: National Vaccine Institute, Department of Disease Control, Ministry of Public Health E-mail: [email protected] Tel: +66-25903196
Suchada Jiamsiri Current Position: Medical Officer Organization: Bureau of General Communicable Diseases, Department of Disease Control, Ministry of Public Health E-mail: [email protected] Tel: +66-818105664
The United States Jonathan Schwartz Current Position: Professor Organization: State University of New York, New Paltz E-mail: [email protected] Tel: +1-845-257-2627
Steven Black Current Position: Professor of PediatricsOrganization: Center for Global Health, University of Cincinnati Children’s Hospital E-mail: [email protected] Tel: +1-510-2197372
Viet Nam Hoa Le Kim Current Position: Deputy Director Organization: Institute of Vaccine and Medical Biologicals (IVAC) E-mail: [email protected]; [email protected] Tel: +84-903-504198
Pham Van Hung Current Position: Vice DirectorOrganization: National Institute of Control of Vaccine and Biologicals (NICVB) E-mail: [email protected] Tel: +84-4-3559-3014
APEC Workshop on Influenza Vaccine Policies and
Strategies in Post-Pandemic Era
Wednesday, 18 July 2012
Time Subject Speaker
09:00-09:30 Registration
09:30-09:50 Opening Remarks
Prof. Wen-Ta Chiu
Minister, Department of Health,
Chinese Taipei
09:50-10:00 Group Photo (Invited Guests)
10:00-10:30 Coffee Break
Keynote Speeches
10:30-11:10Influenza Vaccines in the Post-
Pandemic Period
Prof. Ian Gust
Professorial Fellow, Department
of Microbiology and Immunology,
The University of Melbourne,
Australia
11:10-11:50
Vaccination Campaign for
Influenza Pandemic in Chinese
Taipei
Prof. Feng-Yee Chang
Director-General, Centers for
Disease Control, Chinese Taipei
11:50-13:40 Lunch Break
Session I: Vaccination Policy Formulation
Moderator: Prof. Ian Gust
Professorial Fellow, Department of Microbiology and Immunology,
The University of Melbourne, Australia
Prof. Tzou-Yien Lin
Deputy Minister, Department of Health, Chinese Taipei
13:40-14:10
Vaccination Policy
Formulation: Planning,
Refining and Participating
Prof. Don-Yun Chen
Professor, Department of Public
Administration, National
Chengchi University, Chinese
Taipei
14:10-14:40
Lessons Learnt from
(HIN1)2009 Influenza
Pandemic for Preparedness
Against Future Pandemics
Prof. Masato Tashiro
Director, WHO Collaborating
Centre for Reference and
Research on Influenza. Influenza
Virus Research Center, National
Institute of Infectious Diseases,
Japan
14:40-14:50 Q&A
14:50-15:20 Coffee Break
15:20-16:00 Group Discussion
16:00-17:00 Group Report & Open Discussion
17:00-17:20 Group Photo (All Participants)
18:00-20:00 Welcome Party
Thursday, 19 July 2012
Time Subject Speaker
08:30-09:00 Registration
Session II: Vaccination Program Implementation
Moderator: Dr. Thomas Ho-Fai Tsang
Controller, Centre for Health Protection, Department of Health, Hong
Kong, China
Prof. Feng-Yee Chang
Director-General, Centers for Disease Control, Chinese Taipei
09:00-09:30
Vaccine Program
Implementation in Low
Resource Settings
Prof. Cecilia Ladines-Llave
Professor, Department of
Gynecologic Oncology, The
Cancer Institute Foundation,
University of the Philippines
Manila - Philippine General
Hospital, The Philippines
09:30-10:00Evaluation of Immunization
Campaign Against H1N1
Dr. Young-Joon Park
Medical Officer, Division of
Vaccine Preventable Diseases
Control and National
Immunization Programme, Korea
Centers for Disease Control and
Prevention, Republic of Korea
10:00-10:10 Q&A
10:10-10:40 Coffee Break
10:40-11:20 Group Discussion
11:20-12:20 Group Report & Open Discussion
12:20-13:40 Lunch Break
Session III: Vaccine Safety Monitoring
Moderator: Dr. Meir-Chyun Tzou
Director, Division of Drugs and New Biotechnology Products, Food
and Drug Administration, Chinese Taipei
Prof. Fu-Yuan Huang
Professor, Pediatric Department, Mackay Memorial Hospital,
Chinese Taipei
13:40-14:10
Evaluation of the Risk of
Adverse Events Following
Pandemic Influenza Vaccine:
The Importance of International
Collaboration
Prof. Steven Black
Professor, Center for Global
Child Health, University of
Cincinnati Children’s Hospitals,
The United States
14:10-14:40
Building Vaccine Safety
Monitoring Infrastructure in
Chinese Taipei: Experience
from Adverse Events Following
Immunization (AEFI)
Surveillance of Pandemic
Influenza Vaccination
Dr. Angela W.F. On
Chief Executive Director, Taiwan
Drug Relief Foundation, Chinese
Taipei
14:40-14:50 Q&A
14:50-15:20 Coffee Break
15:20-16:00 Group Discussion
16:00-17:00 Group Report & Open Discussion
Friday, 20 July 2012
Time Subject Speaker
08:30-09:00 Registration
Session IV: Communication for Vaccination Programme
Moderator: Prof. Ih-Jen Su
Director, National Institute of Infectious Diseases and Vaccinology,
National Health Research Institutes, Chinese Taipei
Dr. Jih-Haw Chou
Deputy Director-General, Centers for Disease Control, Chinese
Taipei
09:00-09:30
Risk Communication between
Health Scientists/Experts and
the Lay Public
Prof. Mei-Ling Hsu
Professor, Department of
Journalism, College of
Communication, National
Chengchi University, Chinese
Taipei
09:30-10:00
Communications on Influenza
Vaccination Program: Pitfalls
and Lessons in Hong Kong
Dr. Thomas Ho Fai Tsang
Controller, Centre for Health
Protection, Department of Health,
Hong Kong, China
10:00-10:10 Q&A
10:10-10:30 Coffee Break
10:30-11:10 Group Discussion
11:10-12:10 Group Report & Open Discussion
12:10-12:30 Closing Ceremony
Prof. Tzou-Yien Lin
Deputy Minister, Department of
Health, Chinese Taipei
Project Title: APEC Workshop on Influenza Vaccine Policies and Strategies in Post-Pandemic Era
1. For Moderators & Speakersa. What were your roles before, during, and after the activity?
After the activity I will conduct better meeting on influenza vaccine deploy plan. Strategy formulation, program planning, risk communication Planning and revision of vaccination program in Korea.
b. Do you think the project achieved its objectives? What were the projects’ results/achievements? Yes, improved understanding of the regional situation with pandemic of the
planning / vaccination. Yes. Share information on different solution of each economy so we can learn
and prepare more on vaccine policy and safety. To find the challenge and identify the problem
c. Were the attendees the most appropriate target group? Yes. They are knowledgeable and ask the right questions. Yes, most of them are appropriate. Most of attendees capable to certain level for the meeting of the workshop.
d. What is your assessment of the overall effectiveness of the project? High. Great chance of networking with regional partners. Excellent time control
allows ample time for discussion. This workshop has covered all areas concern about. High
e. Was there any room for improving the project? If so, how? Nil Nil
f. Any other suggestions: Continued communications / exchanges with regional partners. Nil
2. For Participants：a. How have you or your economy benefited from the project? Exchange and share experience with other economies. For better preparedness of next pandemic flu. To prepare for pandemic influenza in the face, especially in a cross sectoral and
nation
Sharing with/and learning from other economies in regard to the vaccines polices
and strategies. All information in this project useful for FDA and EPI in my economy; to make
vaccination policies in future. Yes, I have. Lessons learned from experiences of other economies and presentation by the
speakers in various concepts. Networking & Sharing of information / knowledge / experience We are revising the national plan of pandemic influenza preparedness. I’ll feed-
upto my colleagues what I’ve heard about the experiences of others, and refer when revising process.
Yes. I learn a lot from workshop also it has a good chance to share the experiences
among APEC economies. Greater understanding of comparative pandemic preparedness. Lessons to learn
from the experience of other countries. We can compare the influenza vaccine policies between different economies. Good I learned a lot about how each economy reacted to the influenza pandemic. Learn other economies experience. Fair. We were able to raise issues regarding the pandemic preparedness or response of
our country of address the gaps in its implementation. Good. Yes. Information sharing on influenza vaccine in various economies.
b. What new skills, knowledge, or value have you gained? The hospitality shown by Taiwanese is very impressive. To learn the vaccination system in Australia, Korea, the Philippines and Thailand. Taiwan and Hong Kong’s experience on vaccine campaign. Knowledge and realities on the flu vaccine (H1N1). In a cross sectoral coordination Greater knowledge of SOPs in various economies, the challenge and solution to
vaccine related challenges. Management of adverse event of immunization. H5N1 vaccine is available
Introduction of HPV vaccine is undergoing in some places. AEPI data analysis and report New information updated relates influenza virus strains. Safety vaccination program. Planning vaccine public engagement. Preparedness is key importance. Taiwanese are friendly and helpful. As APEC members, we should all be intercommunicated, work together as a team,
share information and work toward one goal. Experience from other economies. Lesson learnt from APEC economies that implementing all flu vaccination. Electronic post marketing surveillance of vaccine Importance of planning / training on risk communication skills Better understanding of how economies deal with pandemic vaccine programs. We gained the knowledge about influenza viruses, vaccines and communications. The implementation of vaccine in each economy. Policy formulation and new risk communication skills. Learnt from other economies experience I learned about the successes and failures of vaccination programs all around the
world.c. What, if any, changes do you plan to pursue in your home economy as a
result of the project? Assess the need of flu vaccine –epidemiologically. Yes. Active surveillance for AEFI. How to improve pre-pandemic vaccine. Building infrastructure in the face of pandemic influenza. None so far. To improve the implementation on sharing information between FDA, EPI,
Media and manufacture.
Yes, we will improve the vaccine safety monitoring system. Review epidemiological data of influenza N/A Good working of harmonious relationship with the media. Update documents on national influenza pandemic preparedness. Sharing and advocacy for training and planning of enhanced surveillance
system.
Better promotion between seasonal influenza vaccination program and success in
pandemic vaccine program. Include lay public in the discussion. To enhanced the risk communication skills. Not sure I will share my knowledge with my colleagues.
d. What needs to be done next? How should the project be built upon? Should then be a need to introduce influenza vaccine to the general population,
though evaluation must be done and there are few issues need to be considered i.e. matching, immunization, response etc.
Infectious disease surveillance for emerging infectious diseases Epidemiology and public health policy. Capacity building. If possible, more keynote speakers can be invited. I think should spend more time for group discussion. Need to establish an interconnected electronic system to allow for surveillance,
registration and evaluation. How to improve pre-pandemic vaccine. Stronger international cooperation conveys APEC members built upon trust and
sharing of recourse. Review and update of pandemic influenza preparedness as part of overall /general
preparedness plans Conduct review meeting on policy/ strategy of flu vaccine. Identify representatives of the lay public. Sharing experience is great, should do more. Set up the implementation scheme for pandemic event. Discussion about seasonal influenza vaccine program in the region where there
can be strengthened.
Vaccine is but one component of pandemic preparedness and response. Expanding to include other aspects of pandemic response.
Hold workshops regard other issues like post marketing drug analysis.e. Is there any plan to link the project’s outcomes to subsequent collective
actions by fora or individual actions by economies? As above, outcome shall be presented to the next policy and practice on
immunization. Yes
There are no plans Yes. We can do better in 1. Vaccine supply and providing 2. Adverse event data
compiling and analysis. Not yet. Not sure. I think that should be organizing workshop every year for APEC members
opportunity sharing experience. Should link to general economy preparedness plans to public health emergencies
(APSED strategy), WHO, WPRO/SEARO. APSED meeting We’ll try to share and provide feedback to our respective economy. Not yet. Yes To be considered on return to Australia possibility yes.
f. Please use the same scale to rate the project on an overall basis. [5] [4] [3] [2] [1]
(Good) (Poor)Result: 60% 30% 10% g. What is your assessment of the overall effectiveness of the project?
Good Objectives attained but effectiveness will be determined after the inputs/outputs
have been properly disseminated to the member economies for utilization. This project is very useful. Communication, training. Good Very effective. Good I think this project successfully. Good Good meeting/ success meeting/ meet with my needs Excellent, all issues on vaccine policy planning and safety covered during
workshop. Excellent Fair Good Project reached its intended objectives. Very useful and effective workshop
Excellent Presentations were very informative.
h. Was the project content: (Check One)Just Right ___ Too Detailed ___ Not Detailed Enough ___
Result: 85% 0% 15% i. Please provide any additional comments. How to improve the project, if any? Give more time for the group discussions so that all questions can be answered. 1. Needs to invite more scholars from academic 2. Epidemiology is not
emphasized for public health policy decision-making 3. Good at group discussion and Taiwan-CDC’s coordination 4. Better planning to compile different policies such as school closures, class suspension in different economies can be compared and concluded.
None so far. The organizer of project should send content of project for all participants before
one or two week. Invite more economies, international organizations, NGOs enterprises. Have website to put all the materials/surveys. And recommendations to be
accessed by participant/member states.
I could learn the expediency, policies and implementation of other economies very
much. But I could not provide enough information for the others as I only deal with pandemic influenza, not general immunization programme.
Allow more time for discussion and limit to 2 group presentations per session to save time.
As noted earlier, expand focus to other aspects of pandemic response and control such as state-society relations, inter and intra government collaboration, containment and migration efforts.
Very well organized. Excellent speakers.
